permission
Scope
Date
~
-
Bio & PharmaDaewoong wins permission for Nabota in Argentina
South Korea's Daewoong Pharmaceutical Co. announced on Monday that its botulinum toxin Nabota received product approval from Argentina's National Ad...
Jul 15, 2024 (Gmt+09:00)
-
EnergyUS court rules in favor of Korea's nuclear reactor exports
A US district court on Monday dismissed Westinghouse Electric Corp.’s lawsuit against South Korean state-run companies to block their nuclear ...
Sep 19, 2023 (Gmt+09:00)
-
Bio & PharmaDaewoong Pharma wins permission from Singapore for Nabota
South Korea's drug development company Daewoong Pharmaceutical said on Thursday that it received on Jan. 20 product approval for its botulinum toxin...
Feb 10, 2023 (Gmt+09:00)
-
Bio & PharmaCelltrion Healthcare launches anti-cancer biosimilar Vegzelma in Japan
Celltrion Healthcare Co. Ltd. said on Thursday that it launched Vegzelma, a biosimilar to the anti-cancer drug Avastin (active ingredient: bevacizum...
Jan 26, 2023 (Gmt+09:00)
-
BiosimilarsSamsung Bioepis gets nod for sale of ophthalmology biosimilar in Europe
South Korea’s biopharmaceutical company Samsung Bioepis Co. won approval from European authorities for sale of Byooviz, its ophthalmology bios...
Aug 23, 2021 (Gmt+09:00)
language
Latest News
- 1 BMW Surpasses Mercedes in Sales – Imported Car Market 'Shake-Up'
- 2 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 3 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 4 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 5 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
